nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2013, 03, v.22 147-150
复方磺胺甲(口恶)唑对环孢素A在兔体内药动学特征的影响
基金项目(Foundation): 温州市科技计划项目(编号Y20090158、Y20090048)
邮箱(Email):
DOI: 10.19577/j.cnki.issn10074406.2013.03.004
发布时间: 2013-05-25
出版时间: 2013-05-25
移动端阅读
摘要:

目的研究复方磺胺甲(口恶)唑(SMZco)对环孢素A(CsA)在兔体内药动学特征的影响。方法 6只(?)性日本大耳白兔,采用自身对照法,予CsA 9 mg·kg-1,ig,bid,连续灌胃给药7 d,于第8天应用LC-MS方法测定兔体内CsA浓度,DAS软件分析其药动学特征。完成CsA浓度检测后,即联用SMZco,37 mg·kg-1,ig,bid,1周后再次测定CsA的药动学特征,获得主要药动学参数,统计分析。结果联用SMZco前后CsA在兔体内的主要药动学参数分别是AUC0→∞(9 262.764±3 060.376)、(5 729.079±343.687)μg·h·L-1;MRT0→∞(14.669±6.487)、(5.973±1.409)h;t1/2(8.791±4.321)、(3.14±1.356)h;ρmax(784.4±392.59)、(1 066.833±279.593)μg·L-1。联用SMZco后CsA的AUC0→∞,MRT和t1/2均缩短,且差异均有统计学意义(P<0.05)。结论 SMZco与CsA联合给药时,可促进CsA的体内代谢,缩短体内滞留时间。

Abstract:

AIM To study the effect of compound sulfamethoxazole(SMZco) on pharmacokinetics of cyclosporin A(CsA)in rabbits.METHODS Six rabbits were randomly involved in a self-controlled study,and 9 mg·kg-1 CsA was administrated intragastrically twice a day for a week.The concentrations of CsA were determined by LC-MS method at 8d and the pharmacokinetic parameters were analyzed by DAS software.Subsequendy,SMZco 37 mg·kg-1 combined with CsA were administrated intragastrically twice a day for a week,then the phannacokinetic parameters of CsA in rabbits were determined using the same method as above.All data were analyzed by statistical method.RESULTS The pharmacokinetic parameters of CsA before and after administration with SMZco were AUC0→∞(9 262.764±3 060.376),(5 729.079±343.687)μg·h·L-1;MRT0→∞(14.669±6.487),(5.973±1.409)h;t1/2(8.791±4.321),(3.14±1.356)h;ρmax(784.4±392.59),(1066.833±279.593)μg·L-1,respectively.The AUC,MRT and t1/1 of CsA all increased after administration with SMZco(P < 0.05).CONCLUSION The metabolism of CsA will be promoted and the residence time will be decreased in rabbits when combined with SMZco.

参考文献

[1]Marioni G,Perin N,Tregnaghi A,et al.Progressive bilateral sensorineural hearing loss probably induced by chronic cyclosporin A treatment after renal transplantation for focal glomerulosclerosis[J].Acta Otolaryngol,2004,124(5):603.

[2]石磊,骆科,姚小莉,等.肾移植术后环孢素A的血药浓度监测[J].广东医学,2004,25(9):1057.

[3]Crozier F.Pneumocystis carinii pneumonia prophylaxis:current therapies and recommendationstJ].J Pediatr Oncol Nurs,2011,28(3):179.

[4]Lindemulder S,Albano E.Successful intermittent prophylaxis with trimethoprim/sulfamethoxazole 2 days per week for Pneumocystis carinii(jiroveci)pneumonia in pediatric oncology patients[J].Pediatrics,2007,120(1):e47.

[5]Tomonari A,Takahashi S,Ooi J,et al.No occurrence of Pneumocystis jiroveci(carinii)pneumonia in 120 adults undergoing myeloablative unrelated cord blood transplantation[J].Transpl Infect Dis,2008,10(5):303.

[6]Fayet A,BeguinA,de Tejada BM,et al.Determination of unbound antiretroviral drug concentrations by a modified ultrafiltration method reveals high variability in the free fraction[J].Ther Drug Monit,2008,30(4):511.

[7]钱小蔷,张九如,汤坚,等.厄贝沙坦、氯沙坦对兔体内环孢素A药动学的影响[J].中国药房,2010,21(9):804.

[8]吕志勇,汪运礼,周宗华.联苯双酯对家兔体内环孢菌素A的药动学影响[J].中国医院药学杂志,2002,22(8):456.

[9]蔡大伟.地奥心血康在兔体内对环孢素药动学的影响[J].中国药师,2004,7(4):249.

[10]邵丽佳,徐瑞龙,朱以军.肾移植患者口服环孢素A的血药浓度监测分析[J].中国现代应用药学杂志,2007,24(3):247.

[11]裴云萍,谈恒山,方芸,等.肾移植术后环孢素血药浓度监测指标的探讨[J].中国临床药学杂志,2007,16(2):108.

基本信息:

DOI:10.19577/j.cnki.issn10074406.2013.03.004

中图分类号:R96

引用信息:

[1]周晓洁,张秀华,胡卢丰,等.复方磺胺甲(口恶)唑对环孢素A在兔体内药动学特征的影响[J].中国临床药学杂志,2013,22(03):147-150.DOI:10.19577/j.cnki.issn10074406.2013.03.004.

基金信息:

温州市科技计划项目(编号Y20090158、Y20090048)

发布时间:

2013-05-25

出版时间:

2013-05-25

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文